Literature DB >> 27727455

Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.

X Diao1, M A Huestis1,2.   

Abstract

We review approaches for determining metabolism of new synthetic cannabinoids (SCs), and challenges and advances in identifying optimal urinary marker metabolites of SC intake. Metabolic patterns of different SC generations are evaluated, and a practical strategy offered for selecting SC urinary marker metabolites. Novel SCs are incubated with human hepatocytes, the most abundant and characteristic metabolites are identified with high-resolution mass spectrometry, and proposed hepatocyte marker metabolites are confirmed in authentic positive urine samples. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27727455     DOI: 10.1002/cpt.534

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

Review 1.  Interpol review of toxicology 2016-2019.

Authors:  Wing-Sum Chan; George Fai Wong; Chi-Wai Hung; Yau-Nga Wong; Kit-Mai Fung; Wai-Kit Lee; Kwok-Leung Dao; Chung-Wing Leung; Kam-Moon Lo; Wing-Man Lee; Bobbie Kwok-Keung Cheung
Journal:  Forensic Sci Int       Date:  2020-05-23       Impact factor: 2.395

2.  Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes.

Authors:  Jeremy Carlier; Xingxing Diao; Cristina Sempio; Marilyn A Huestis
Journal:  AAPS J       Date:  2017-01-09       Impact factor: 4.009

3.  A regenerable sorbent composed of a zeolite imidazolate framework (ZIF-8), Fe3O4 and graphene oxide for enrichment of atorvastatin and simvastatin prior to their determination by HPLC.

Authors:  Jun Peng; Huairu Tian; Qiuzheng Du; Xuanhong Hui; Hua He
Journal:  Mikrochim Acta       Date:  2018-01-27       Impact factor: 5.833

4.  Structural Elucidation of Metabolites of Synthetic Cannabinoid UR-144 by Cunninghamella elegans Using Nuclear Magnetic Resonance (NMR) Spectroscopy.

Authors:  Shimpei Watanabe; Unnikrishnan Kuzhiumparambil; Shanlin Fu
Journal:  AAPS J       Date:  2018-03-08       Impact factor: 4.009

5.  Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans.

Authors:  Shimpei Watanabe; Unnikrishnan Kuzhiumparambil; My Ann Nguyen; Jane Cameron; Shanlin Fu
Journal:  AAPS J       Date:  2017-04-28       Impact factor: 4.009

6.  Analytical Methodologies for the Characterization and Analysis of the Parent Compound and Phase I Metabolites of 4F-MDMB-BICA in Human Microsome, Urine, and Blood Samples.

Authors:  Tímea Körmöczi; Éva Sija; László Institóris; Éva M Kereszty; István Ilisz; Róbert Berkecz
Journal:  J Anal Toxicol       Date:  2021-01-06       Impact factor: 3.367

7.  Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE.

Authors:  Lukas Mogler; Sebastian Halter; Maurice Wilde; Florian Franz; Volker Auwärter
Journal:  Forensic Toxicol       Date:  2018-10-05       Impact factor: 4.096

Review 8.  New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites.

Authors:  Xingxing Diao; Marilyn A Huestis
Journal:  Front Chem       Date:  2019-03-04       Impact factor: 5.545

Review 9.  Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy.

Authors:  Bogdan Ionel Tamba; Gabriela Dumitrita Stanciu; Cristina Mariana Urîtu; Elena Rezus; Raluca Stefanescu; Cosmin Teodor Mihai; Andrei Luca; Gabriela Rusu-Zota; Maria-Magdalena Leon-Constantin; Elena Cojocaru; Bogdan Gafton; Teodora Alexa-Stratulat
Journal:  Medicina (Kaunas)       Date:  2020-01-09       Impact factor: 2.430

10.  In vitro metabolism of synthetic cannabinoid AM1220 by human liver microsomes and Cunninghamella elegans using liquid chromatography coupled with high resolution mass spectrometry.

Authors:  Shimpei Watanabe; Unnikrishnan Kuzhiumparambil; Shanlin Fu
Journal:  Forensic Toxicol       Date:  2018-05-24       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.